ETF Home ETF List Shorted Stocks Home About

ETF Holdings Breakdown of TMO

Stock NameTime Out Group plc
TickerTMO(GBX) LSE
TYPECommon Stock
CountryUK
ISINGB00BYYV0629
LEI213800BWH4OF8S4R8K10

TMO institutional holdings

The adjusted close for TMO on 2025-12-24 was 579.12

The following institutional investment holdings of TMO have been identified

Date ETF ISIN/Name Num Shares Book value Derived Price per Share Comment
2025-12-24 IE00019GPKX6 (iShares MSCI ACWI UCITS ETF SGD Hedged (Acc)) 103,730USD 60,072,118 -0.1% 579.12  
2025-12-24 IE0001YGXFO5 (iShares MSCI World Climate Transition Aware UCITS ETF USD (Acc)) 57USD 33,010 -0.1% 579.12  
2025-12-24 IE0002EKOXU6 (iShares Russell 1000 Value UCITS ETF) 3,506USD 2,030,395 -0.1% 579.12  
2025-12-24 IE0002W8NB38 (iShares MSCI USA Swap UCITS ETF USD (Acc)) 76,874 148.5%USD 44,519,271 148.6% 579.12  
2025-12-24 IE0003WV2ME7 (iShares S&P 500 Equal Weight UCITS ETF GBP Hedged (Acc)) 14,623USD 8,468,472 -0.1% 579.12  
2025-12-24 IE0009QS7W62 (iShares MSCI World Health Care Sector ESG UCITS ETF USD (Acc)) 22,956USD 13,294,279 -0.1% 579.12  
2025-12-24 IE000D3BWBR2 (iShares S&P 500 Swap UCITS ETF USD (Dist)) 419,535 158.8%USD 242,961,109 158.9% 579.12  
2025-12-24 IE000G2LIHG9 (iShares MSCI USA ESG Screened UCITS ETF EUR Hedged (Acc)) 127,298USD 73,720,818 -0.1% 579.12  
2025-12-24 IE000G4PH2B1 (iShares S&P 500 Paris-Aligned Climate UCITS ETF USD Dist) 4,531USD 2,623,993 -0.1% 579.12  
2025-12-24 IE000MGAVJV3 (iShares MSCI USA Climate Transition Aware UCITS ETF USD (Acc)) 54USD 31,272 -0.1% 579.11 Warning! :Potential incorrect reporting.Incorrect share price reported. Should be 579.12 not 579.11. May be due to incorrect reporting of currency . Could be EUR or USD instead 
2025-12-24 IE000MLMNYS0 (iShares S&P 500 Equal Weight UCITS ETF USD (Acc)) 14,623USD 8,468,472 -0.1% 579.12  
2025-12-24 IE000OHHIBC6 (iShares Core MSCI World UCITS ETF USD (Dist)) 597,740USD 346,163,189 -0.1% 579.12  
2025-12-24 IE000R9FA4A0 (iShares S&P 500 ESG UCITS ETF USD (Acc)) 7,775USD 4,502,658 -0.1% 579.12  
2025-12-24 IE000YG82CF0 (iShares MSCI USA Climate Transition Aware UCITS ETF USD (Dist)) 54USD 31,272 -0.1% 579.11 Warning! :Potential incorrect reporting.Incorrect share price reported. Should be 579.12 not 579.11. May be due to incorrect reporting of currency . Could be EUR or USD instead 
2025-12-24 IE000YNE6S57 (iShares MSCI World Climate Transition Aware UCITS ETF USD (Dist)) 57USD 33,010 -0.1% 579.12  
2025-12-24 IE0031442068 (iShares Core S&P 500 UCITS ETF USD (Dist)) 130,205USD 75,404,320 -0.1% 579.12  
2025-12-24 IE00B0M62Q58 (iShares MSCI World UCITS ETF USD (Dist)) 38,874USD 22,512,711 -0.1% 579.12  
2025-12-24 IE00B14X4M10 (iShares MSCI North America UCITS ETF USD (Dist) USD) 7,698USD 4,458,066 -0.1% 579.12  
2025-12-24 IE00B3Y8X563 (iShares S&P 500 GBP Hedged UCITS ETF (Acc)) 9,037USD 3,874,663 -0.3% 428.76 Warning! :Potential incorrect reporting.Incorrect share price reported. Should be 579.12 not 428.76. May be due to incorrect reporting of currency . Could be EUR or USD insteadIE00B3Y8X563 incorrectly reporting value of holding as USD actually is reported in GBP
2025-12-24 IE00B3ZW0K18 (iShares S&P 500 EUR Hedged UCITS ETF (Acc)) 58,830USD 28,925,270 -0.2% 491.68 Warning! :Potential incorrect reporting.Incorrect share price reported. Should be 579.12 not 491.68. May be due to incorrect reporting of currency . Could be EUR or USD insteadIE00B3ZW0K18 incorrectly reporting value of holding as USD actually is reported in EUR
2025-12-24 IE00B42YS929 (iShares MSCI World GBP Hedged UCITS ETF (Acc)) 2,345USD 1,005,432 -0.3% 428.76 Warning! :Potential incorrect reporting.Incorrect share price reported. Should be 579.12 not 428.76. May be due to incorrect reporting of currency . Could be EUR or USD insteadIE00B42YS929 incorrectly reporting value of holding as USD actually is reported in GBP
2025-12-24 IE00B43HR379 (iShares S&P 500 Health Care Sector UCITS ETF USD (Acc)) 192,048USD 111,218,838 -0.1% 579.12  
2025-12-24 IE00B441G979 (iShares MSCI World EUR Hedged UCITS ETF (Acc)) 25,020USD 12,301,721 -0.2% 491.68 Warning! :Potential incorrect reporting.Incorrect share price reported. Should be 579.12 not 491.68. May be due to incorrect reporting of currency . Could be EUR or USD insteadIE00B441G979 incorrectly reporting value of holding as USD actually is reported in EUR
2025-12-24 IE00B4L5Y983 (iShares Core MSCI World UCITS ETF USD (Acc)) 597,740USD 346,163,189 -0.1% 579.12  
2025-12-24 IE00B52SFT06 (iShares MSCI USA UCITS ETF USD (Acc)) 20,416USD 11,823,314 -0.1% 579.12  
2025-12-24 IE00B5BMR087 (iShares Core S&P 500 UCITS ETF USD (Acc)) 881,928USD 510,742,143 -0.1% 579.12  
2025-12-24 IE00BD45YS76 (iShares Core MSCI World UCITS ETF GBP Hedged (Dist)) 597,740USD 346,163,189 -0.1% 579.12  
2025-12-24 IE00BD8KRH84 (iShares Core S&P 500 UCITS ETF GBP Hedged (Dist)) 881,928USD 510,742,143 -0.1% 579.12  
2025-12-24 IE00BFNM3H51 (iShares MSCI USA ESG Screened UCITS ETF USD (Dist)) 127,298USD 73,720,818 -0.1% 579.12  
2025-12-24 IE00BFNM3J75 (iShares MSCI World ESG Screened UCITS ETF) 31,424USD 18,198,267 -0.1% 579.12  
2025-12-24 IE00BFNM3K80 (iShares MSCI World ESG Screened UCITS ETF USD (Dist)) 31,424USD 18,198,267 -0.1% 579.12  
2025-12-24 IE00BHZPJ569 (iShares MSCI World ESG Enhanced UCITS ETF USD Acc GBP) 8,385USD 4,855,921 1.9% 579.12  
2025-12-24 IE00BHZPJ890 (iShares MSCI USA ESG Enhanced UCITS ETF USD (Dist)) 45,441 0.1%USD 26,315,792 -0.1% 579.12  
2025-12-24 IE00BJ5JNZ06 (iShares MSCI World Health Care Sector ESG UCITS ETF) 22,956USD 13,294,279 -0.1% 579.12  
2025-12-24 IE00BKBF6H24 (iShares Core MSCI World UCITS ETF) 597,740USD 346,163,189 -0.1% 579.12  
2025-12-24 IE00BL3J3G74 (iShares Core S&P 500 UCITS ETF MXN Hedged (Acc)) 881,928USD 510,742,143 -0.1% 579.12  
2025-12-24 IE00BMBKBZ46 (iShares S&P 500 Health Care Sector UCITS ETF) 192,048USD 111,218,838 -0.1% 579.12  
2025-12-24 IE00BMTX1Y45 (iShares S&P 500 Swap UCITS ETF USD (Acc)) 419,535 158.8%USD 242,961,109 158.9% 579.12  
2025-12-24 IE00BMXC7V63 (iShares S&P 500 Paris-Aligned Climate UCITS ETF USD (Acc)) 4,531USD 2,623,993 -0.1% 579.12  
2025-12-24 IE00BMXC7W70 (iShares MSCI World Paris-Aligned Climate UCITS ETF USD (Acc)) 3,180USD 1,841,602 -0.1% 579.12  
2025-12-24 IE00BN92ZL31 (iShares MSCI World Paris-Aligned Climate UCITS ETF USD (Dist)) 3,180USD 1,841,602 -0.1% 579.12  
2025-12-24 IE00BYZK4776 (iShares Healthcare Innovation UCITS ETF USD (Acc)) 35,587USD 20,609,143 -0.1% 579.12  
2025-12-23 IE00B6R52259 (iShares MSCI ACWI UCITS ETF) 103,730 0.4%USD 60,157,176 3.4% 579.94 Warning! :Potential incorrect reporting.Incorrect share price reported. Should be 579.12 not 579.94. May be due to incorrect reporting of currency . Could be EUR or USD instead 
2025-12-23 IE00BFNM3G45 (iShares MSCI USA ESG Screened UCITS ETF USD (Acc)) 127,298 0.4%USD 73,825,202 1.1% 579.94 Warning! :Potential incorrect reporting.Incorrect share price reported. Should be 579.12 not 579.94. May be due to incorrect reporting of currency . Could be EUR or USD instead 
2025-12-23 IE00BG11HV38 (iShares MSCI World ESG Enhanced UCITS ETF USD Inc GBP) 8,385USD 4,862,797 0.7% 579.94 Warning! :Potential incorrect reporting.Incorrect share price reported. Should be 579.12 not 579.94. May be due to incorrect reporting of currency . Could be EUR or USD instead 
Total =7,481,292 USD 4,323,718,475
Book value of shares is calculated on the adjusted close price of each day (row).

News associated with TMO

Guru Fundamental Report for TMO
Below is Validea's guru fundamental report for THERMO FISHER SCIENTIFIC INC (TMO). Of the 22 guru strategies we follow, TMO rates highest using our Low PE Investor model based on the published strategy of John Neff. This strategy looks for firms with persistent earnings growth t - 2025-09-18 10:39:11
TMO Factor-Based Stock Analysis
Below is Validea's guru fundamental report for THERMO FISHER SCIENTIFIC INC (TMO). Of the 22 guru strategies we follow, TMO rates highest using our Low PE Investor model based on the published strategy of John Neff. This strategy looks for firms with persistent earnings growth t - 2025-09-17 10:34:46
XLV, LLY, TMO, PFE: Large Inflows Detected at ETF
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the The Health Care Select Sector SPDR Fund (Symbol: XLV) where we have detected an approximate $308.0 million dollar inflow -- that's a 0.9% increase we - 2025-09-16 11:47:58
Validea Detailed Fundamental Analysis - TMO
Below is Validea's guru fundamental report for THERMO FISHER SCIENTIFIC INC (TMO). Of the 22 guru strategies we follow, TMO rates highest using our Low PE Investor model based on the published strategy of John Neff. This strategy looks for firms with persistent earnings growth t - 2025-09-12 10:32:52
Guru Fundamental Report for TMO
Below is Validea's guru fundamental report for THERMO FISHER SCIENTIFIC INC (TMO). Of the 22 guru strategies we follow, TMO rates highest using our Low PE Investor model based on the published strategy of John Neff. This strategy looks for firms with persistent earnings growth t - 2025-09-11 10:33:22
TMO Factor-Based Stock Analysis
Below is Validea's guru fundamental report for THERMO FISHER SCIENTIFIC INC (TMO). Of the 22 guru strategies we follow, TMO rates highest using our Low PE Investor model based on the published strategy of John Neff. This strategy looks for firms with persistent earnings growth t - 2025-09-10 10:34:15
TMO Quantitative Stock Analysis
Below is Validea's guru fundamental report for THERMO FISHER SCIENTIFIC INC (TMO). Of the 22 guru strategies we follow, TMO rates highest using our Low PE Investor model based on the published strategy of John Neff. This strategy looks for firms with persistent earnings growth t - 2025-09-09 10:34:36
Guru Fundamental Report for TMO
Below is Validea's guru fundamental report for THERMO FISHER SCIENTIFIC INC (TMO). Of the 22 guru strategies we follow, TMO rates highest using our Low PE Investor model based on the published strategy of John Neff. This strategy looks for firms with persistent earnings growth t - 2025-09-04 10:32:26
Thermo Fisher Scientific (NYSE:TMO) CEO Marc Casper Sells 10,000 Shares
Thermo Fisher Scientific Inc. (NYSE:TMO – Get Free Report) CEO Marc Casper sold 10,000 shares of the company’s stock in a transaction that occurred on Friday, August 22nd. The shares were sold at an average price of $500.96, for a total transaction of $5,009,600.00. Following the transaction, the chief executive officer directly owned 115,174 shares […] - 2025-08-28 05:22:48
Head to Head Review: Thermo Fisher Scientific (NYSE:TMO) and PROCEPT BioRobotics (NASDAQ:PRCT)
Thermo Fisher Scientific (NYSE:TMO – Get Free Report) and PROCEPT BioRobotics (NASDAQ:PRCT – Get Free Report) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, valuation, risk, analyst recommendations, earnings, dividends and institutional ownership. Valuation & Earnings This table compares Thermo […] - 2025-08-25 04:26:46
Notable Wednesday Option Activity: TMO, DE, NKE
Among the underlying components of the S&P 500 index, we saw noteworthy options trading volume today in Thermo Fisher Scientific Inc (Symbol: TMO), where a total of 14,417 contracts have traded so far, representing approximately 1.4 million underlying shares. That amounts t - 2025-08-13 14:51:35
Thermo Fisher Scientific (NYSE:TMO) Rating Lowered to Hold at Wall Street Zen
Thermo Fisher Scientific (NYSE:TMO – Get Free Report) was downgraded by investment analysts at Wall Street Zen from a “buy” rating to a “hold” rating in a note issued to investors on Sunday. TMO has been the subject of several other research reports. Argus lowered their price target on shares of Thermo Fisher Scientific from […] - 2025-08-12 02:40:48
Validea Detailed Fundamental Analysis - TMO
Below is Validea's guru fundamental report for THERMO FISHER SCIENTIFIC INC (TMO). Of the 22 guru strategies we follow, TMO rates highest using our Low PE Investor model based on the published strategy of John Neff. This strategy looks for firms with persistent earnings growth t - 2025-08-08 10:04:07
Thermo Fisher Scientific (NYSE:TMO) Shares Gap Up Following Better-Than-Expected Earnings
Thermo Fisher Scientific Inc. (NYSE:TMO – Get Free Report)’s share price gapped up prior to trading on Wednesday after the company announced better than expected quarterly earnings. The stock had previously closed at $427.62, but opened at $473.26. Thermo Fisher Scientific shares last traded at $476.44, with a volume of 1,341,090 shares. The medical research […] - 2025-07-25 04:26:46
TMO Factor-Based Stock Analysis
Below is Validea's guru fundamental report for THERMO FISHER SCIENTIFIC INC (TMO). Of the 22 guru strategies we follow, TMO rates highest using our Low PE Investor model based on the published strategy of John Neff. This strategy looks for firms with persistent earnings growth t - 2025-07-23 10:34:47
Thermo Fisher Scientific Q2 25 Earnings Conference Call At 8:30 AM ET
(RTTNews) - Thermo Fisher Scientific (TMO) will host a conference call at 8:30 AM ET on July 23, 2025, to discuss Q2 25 earnings results. - 2025-07-23 08:30:30
Pre-Market Earnings Report for July 23, 2025 : T, NEE, GEV, BSX, TMO, APH, CME, FI, MCO, GD, FCX, HLT
The following companies are expected to report earnings prior to market open on 07/23/2025. Visit our Earnings Calendar for a full list of expected earnings releases.AT&T Inc. (T)is reporting for the quarter ending June 30, 2025. The wireless (national) company's consensus e - 2025-07-22 17:00:01
Validea Detailed Fundamental Analysis - TMO
Below is Validea's guru fundamental report for THERMO FISHER SCIENTIFIC INC (TMO). Of the 22 guru strategies we follow, TMO rates highest using our Low PE Investor model based on the published strategy of John Neff. This strategy looks for firms with persistent earnings growth t - 2025-07-18 10:34:50
TMO Factor-Based Stock Analysis
Below is Validea's guru fundamental report for THERMO FISHER SCIENTIFIC INC (TMO). Of the 22 guru strategies we follow, TMO rates highest using our Low PE Investor model based on the published strategy of John Neff. This strategy looks for firms with persistent earnings growth t - 2025-07-16 10:39:52
TMO Quantitative Stock Analysis
Below is Validea's guru fundamental report for THERMO FISHER SCIENTIFIC INC (TMO). Of the 22 guru strategies we follow, TMO rates highest using our Low PE Investor model based on the published strategy of John Neff. This strategy looks for firms with persistent earnings growth t - 2025-07-15 10:35:29
Thermo Fisher Scientific (NYSE:TMO) Upgraded by Scotiabank to “Sector Outperform” Rating
Scotiabank upgraded shares of Thermo Fisher Scientific (NYSE:TMO – Free Report) from a sector perform rating to a sector outperform rating in a research report report published on Friday morning, Marketbeat.com reports. They currently have $590.00 price target on the medical research company’s stock. TMO has been the subject of several other research reports. Robert […] - 2025-07-14 03:46:44
Validea Detailed Fundamental Analysis - TMO
Below is Validea's guru fundamental report for THERMO FISHER SCIENTIFIC INC (TMO). Of the 22 guru strategies we follow, TMO rates highest using our Low PE Investor model based on the published strategy of John Neff. This strategy looks for firms with persistent earnings growth t - 2025-07-11 10:32:18
Guru Fundamental Report for TMO
Below is Validea's guru fundamental report for THERMO FISHER SCIENTIFIC INC (TMO). Of the 22 guru strategies we follow, TMO rates highest using our Low PE Investor model based on the published strategy of John Neff. This strategy looks for firms with persistent earnings growth t - 2025-07-10 10:38:39
TMO Factor-Based Stock Analysis
Below is Validea's guru fundamental report for THERMO FISHER SCIENTIFIC INC (TMO). Of the 22 guru strategies we follow, TMO rates highest using our Low PE Investor model based on the published strategy of John Neff. This strategy looks for firms with persistent earnings growth t - 2025-07-09 10:32:57
TMO Quantitative Stock Analysis
Below is Validea's guru fundamental report for THERMO FISHER SCIENTIFIC INC (TMO). Of the 22 guru strategies we follow, TMO rates highest using our Low PE Investor model based on the published strategy of John Neff. This strategy looks for firms with persistent earnings growth t - 2025-07-08 10:34:57
Validea Detailed Fundamental Analysis - TMO
Below is Validea's guru fundamental report for THERMO FISHER SCIENTIFIC INC (TMO). Of the 22 guru strategies we follow, TMO rates highest using our Low PE Investor model based on the published strategy of John Neff. This strategy looks for firms with persistent earnings growth t - 2025-07-04 10:34:45
TMO Factor-Based Stock Analysis
Below is Validea's guru fundamental report for THERMO FISHER SCIENTIFIC INC (TMO). Of the 22 guru strategies we follow, TMO rates highest using our Low PE Investor model based on the published strategy of John Neff. This strategy looks for firms with persistent earnings growth t - 2025-07-02 10:35:52
Notable ETF Inflow Detected - UPRO, HD, PEP, TMO
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the ProShares UltraPro S&P 500 (Symbol: UPRO) where we have detected an approximate $234.1 million dollar inflow -- that's a 5.5% increase week over - 2025-06-30 11:52:15
Thermo Fisher Scientific (NYSE:TMO) and Masimo (NASDAQ:MASI) Head-To-Head Comparison
Thermo Fisher Scientific (NYSE:TMO – Get Free Report) and Masimo (NASDAQ:MASI – Get Free Report) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, dividends, profitability, valuation, risk and earnings. Profitability This table compares Thermo Fisher Scientific and […] - 2025-06-27 02:38:48
Barclays Issues Pessimistic Forecast for Thermo Fisher Scientific (NYSE:TMO) Stock Price
Thermo Fisher Scientific (NYSE:TMO – Get Free Report) had its price objective reduced by analysts at Barclays from $475.00 to $450.00 in a research note issued on Tuesday,Benzinga reports. The brokerage currently has an “equal weight” rating on the medical research company’s stock. Barclays‘s price objective points to a potential upside of 9.64% from the […] - 2025-06-26 05:16:49

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.

Copyright Market Footprint Ltd. Privacy Policy